Photo of Thomas Schiano

Thomas Schiano

  • PROFESSOR Medicine, Liver Diseases
Print ProfilePrint Profile


  • Transplant Hepatology

  • Gastroenterology


  • American Board of Internal Medicine


  • MD, Universidad Del Noreste

  • Residency, Internal Medicine
    Maimonides Medical Center

  • Fellowship, Clinical Nutrition
    Memorial Sloan-Kettering

  • Fellowship, Gastroenterology
    Temple University Hospital

  • Fellowship, Liver Disease-Trans
    Mount Sinai Hospital


    Dr. Thomas D. Schiano  has a clinical background in hepatology, gastroenterology and clinical nutrition. He has expertise in the management of patients with cirrhosis and other acute/chronic liver diseases, as well as caring for patients prior to and after liver and intestinal transplantation. Dr. Schiano has varied clinical research interests including herbal treatments of liver disease, nutritional aspects of liver disease, recurrence of disease post liver transplantation, living donor liver transplantation, and management of the complications of cirrhosis. In addition, he is member of the liver thrombosis program - an international referral center for adults and children with difficult to diagnose and unique blood clotting disorders affecting the liver and intestines.

    Liver Thrombosis Program

    Dr. Schiano is a professor of medicine, a UNOS-certified Liver Transplant physician, and is board certified in internal medicine, clinical nutrition, and gastroenterology.

    Dr. Schiano is Medical Director of Adult Liver Transplantation and Director of Clinical Hepatology and Intestinal Transplantation at the Recanati/Miller Transplantation Institute.

    RMTI website:


  • 2012 -
    2012 American Liver Foundation Physician of the Year
    American Liver Foundation

  • 2008 - 2013
    Best Doctors
    New York Magazine

  • 2008 - 2013
    Super Doctors
    NY Times Magazine

  • 2008 - 2013
    Castle-Connolly America's Top Doctors

  • 2006 -
    Manhattan Chapter Triangle Award
    TRIO (Transplant Recipients International Organization)

  • 1995 -
    Sol Sherry Award
    Temple University Hospital

  • 1991 -
    Award for Excellence
    Maimonides Medical Center

  • 1990 -
    Award for Excellence
    Maimonides Medical Center

  • 1989 -
    Award for Excellence
    Maimonides Medical Center



Liver transplantation, living donor liver transplantation, herbal and drug hepatotoxicity, nutrition, cirrhosis, intestinal transplantation, recurrence of disease post-liver transplantation, treatment of viral hepatitis post-liver transplantation, herbal and alternative treatments of chronic liver disease, complications of cirrhosis, portal hypertension, cholestasis associated with TPN.


Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012 Jun; 18(6).

Fiel MI, Schiano TD. Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Current opinion in organ transplantation 2012 Jun; 17(3).

Levitsky J, Fiel MI, Norvell JP, Wang E, Watt KD, Curry MP, Tewani S, McCashland TM, Hoteit MA, Shaked A, Saab S, Chi AC, Tien A, Schiano TD. Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology 2012 May; 142(5).

Fiel MI, Deniz K, Elmali F, Schiano TD. Increasing hepatic arteriole wall thickness and decreased luminal diameter occur with increasing age in normal livers. Journal of hepatology 2011 Sep; 55(3).

Stanca CM, Montazem AH, Lawal A, Zhang JX, Schiano TD, Branch AD, Nelson C, Bodenheimer H, Thung S, Chung RT, Schwartz ME, Cheng B. Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2010 Jan; 68(1).

Fiel MI, Sauter B, Wu HS, Rodriguez-Laiz G, Gondolesi G, Iyer K, Schiano TD, Dagan S, Graham N, Williams PV, Tur-Kaspa R. Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008 Aug; 6(8).

Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, Andrews J, Eren R, Dagan S, Graham N, Williams PV, Tur-Kaspa R. Monoclonal antibody HCV-AbxTL68 in patients undergoing liver transplantation for HCV: Results of a Phase 2 randomized study. Liver Transpl 2006; 12: 1381-1389.

Poonawala Khapra A, Agarwal K, Fiel MI, Schiano TD, Hossain S, Emre S, Kontorinis N. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using hepatitis C+ allografts. Liver Transpl 2006; 12: 1496-1503.

Carmiel-Haggai M, Fiel MI, Gaddipati HC, Abittan C, Schiano TD, Roayaie S, Emre S, Gondolesi G, Schwartz M, Hossain S. Frequency of hepatitis C recurrence and factors affecting patient outcome after re-transplantation for recurrent hepatitis C. Liver Transpl 2005; 11: 1567-1573.

Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Fernandez EJ, Branch AD, Nelson C, Bodenheimer H, Thung S, Chung RT, Schwartz ME, Cheng B. HCV levels rise quickly in liver transplant patients with live donors, persistent ALT elevations often follow. Hepatology 2005; 42: 1420-1428.

Harpaz N, Schiano TD, Ruf AE, Sauter BV, Tao Y, Fishbein TM, Shukla D. Early and frequent histological re-currence of Crohn's disease in small intestinal allografts. Transplantation 2005; 80: 1667-1670.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Schiano during 2015 and/or 2016. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • Biotest International; Bristol-Myers Squibb / sanofi-aventis Partnership; Gilead Sciences, Inc.; Pfizer Inc.; Salix Pharmaceuticals, Inc.

Scientific Advisory Board:

  • Bristol-Myers Squibb / sanofi-aventis Partnership; Gilead Sciences, Inc.; Idenix Pharmaceuticals; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Synageva BioPharma

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • Novartis

Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.

  • Biotest International; Genentech, Inc.; Salix Pharmaceuticals, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


Icahn (East) Building Floor 3rd Floor
1425 Madison Avenue
New York, NY 10029

Fax: 212-241-2138
RMTI - Liver Diseases Practice

5 East 98th Street
12th Floor, Box 1104
New York, NY 10029

Tel: 212-241-0034
Fax: 212-241-2138
Get Directions
  • Spanish
  • Russian
Insurance Plans
  • 1199 Home Care Division Benefit
  • 1199 National Benefit Fund
  • Aetna U.S. Healthcare
  • Beech Street
  • Best Doctor
  • Blue Choice
  • Blue Cross/ Blue Shield
  • Blue Cross/ Blue Shield - HMO
  • Choice Care
  • Cigna - HMO
  • Devon Health Services
  • Empire Blue Cross/ Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - PPO
  • Fidelis Care NY
  • First Health
  • GHI HMO Select, Inc.
  • Group Health Insurance, Inc.
  • Health Insurance Plan (HIP)
  • HealthFirst/Medicaid HMO
  • HealthNet
  • HealthPlus, Inc.
  • Island Group
  • Local 32BJ - PPO
  • Magnacare
  • Medicaid
  • Medicaid New Jersey
  • Medicare
  • Mount Sinai Health System
  • Neighborhood Health Providers, LLC
  • Oxford Health Plans
  • Private Healthcare Systems (PHCS)
  • Railroad Medicare
  • Statewide
  • Travel Care Services
  • United Healthcare
  • United Healthcare Empire Plan
  • Vytra
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Personal Check
  • Cash

RMTI - Liver Transplantation Practice

5 East 98th Street
12th Floor
New York, NY 10029

Tel: 212-241-8035
Fax: 212-731-7245
Get Directions